Cargando…

Impact of mTOR expression on clinical outcome in paediatric patients with B-cell acute lymphoblastic leukaemia – preliminary report

AIM OF THE STUDY: To characterise expression of mTOR (mammalian target of rapamycin) in childhood B-cell acute lymphoblastic leukaemia (ALL), and to evaluate a possible link between mTOR and clinical characteristics. MATERIAL AND METHODS: The examined group consisted of 21 consecutive patients, aged...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ulińska, Edyta, Mycko, Katarzyna, Sałacińska-Łoś, Elżbieta, Pastorczak, Agata, Siwicka, Alicja, Młynarski, Wojciech, Matysiak, Michał
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032156/ https://www.ncbi.nlm.nih.gov/pubmed/27688725 http://dx.doi.org/10.5114/wo.2016.61848

Ejemplares similares

Ovarian carcinoma in children with constitutional mutation of SMARCA4: single-family report and literature review
por: Pastorczak, Agata, et al.
Publicado: (2021)

Case report: Successful allogeneic stem cell transplantation in a child with novel GATA2 defect associated B-cell acute lymphoblastic leukemia
por: Heropolitańska-Pliszka, Edyta, et al.
Publicado: (2022)

Role of apoptotic markers in paediatric acute lymphoblastic leukaemia
por: Kapoor, Gauri, et al.
Publicado: (2018)

The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia
por: Janczar, Szymon, et al.
Publicado: (2017)

Targeting mTOR in Acute Lymphoblastic Leukemia
por: Simioni, Carolina, et al.
Publicado: (2019)

Advantages and Limitations of SNP Array in the Molecular Characterization of Pediatric T-Cell Acute Lymphoblastic Leukemia
por: Lejman, Monika, et al.
Publicado: (2020)

Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities
por: López Villar, Elena, et al.
Publicado: (2014)

Prediction of leukocyte counts during paediatric acute lymphoblastic leukaemia maintenance therapy
por: Karppinen, Santeri, et al.
Publicado: (2019)

The Role of MicroRNA in Paediatric Acute Lymphoblastic Leukaemia: Challenges for Diagnosis and Therapy
por: Grobbelaar, Carle, et al.
Publicado: (2019)

Germline 3p22.1 microdeletion encompassing RPSA gene is an ultra-rare cause of isolated asplenia
por: Oszer, Aleksandra, et al.
Publicado: (2021)

Osteonecrosis in Korean Paediatric and Young Adults with Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma: A Nationwide Epidemiological Study
por: Hahn, Seung Min, et al.
Publicado: (2022)

The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia
por: Urbańska, Zuzanna, et al.
Publicado: (2022)

Targeting the thioredoxin system as a novel strategy against B‐cell acute lymphoblastic leukemia
por: Fidyt, Klaudyna, et al.
Publicado: (2019)

Secondary acute lymphoblastic leukaemia in a multiple myeloma patient
por: Piszcz, Jaroslaw, et al.
Publicado: (2013)

New Insights into Red Blood Cell Microcytosis upon mTOR Inhibitor Administration
por: Jakubowska, Justyna, et al.
Publicado: (2021)

Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
por: Evangelisti, Camilla, et al.
Publicado: (2018)

Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression
por: Toscan, Cara E., et al.
Publicado: (2020)

MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

Influence of genomic variation in FTO at 16q12.2, MC4R at 18q22 and NRXN3 at 14q31 genes on breast cancer risk
por: Kusinska, Renata, et al.
Publicado: (2011)

Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey
por: Bobeff, Katarzyna, et al.
Publicado: (2023)

Oral mucositis in children suffering from acute lymphoblastic leukaemia
por: Pels, Elżbieta
Publicado: (2012)

Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia
por: Pastorczak, Agata, et al.
Publicado: (2021)

Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions
por: Pastorczak, Agata, et al.
Publicado: (2018)

Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity
por: Kutszegi, Nóra, et al.
Publicado: (2015)

Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions
por: Venn, Nicola C., et al.
Publicado: (2022)

Superior mediastinal syndrome in paediatric B-cell acute lymphoblastic leukaemia: a case report
por: Rahat-Ul-Ain,, et al.
Publicado: (2022)

The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia
por: Chulián, Salvador, et al.
Publicado: (2023)

MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL
por: Wrona, Ewa, et al.
Publicado: (2019)

Overweight and obesity management strategies in survivors of paediatric acute lymphoblastic leukaemia: a systematic review protocol
por: Ladhani, Salma, et al.
Publicado: (2018)

Blinatumomab as bridging therapy in paediatric B‐cell acute lymphoblastic leukaemia complicated by invasive fungal disease
por: Yeoh, Daniel K., et al.
Publicado: (2022)

Paediatric pre‐B acute lymphoblastic leukaemia‐derived exosomes regulate immune function in human T cells
por: Gholipour, Elham, et al.
Publicado: (2022)

mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

Novel FANCA mutation in the first fully-diagnosed patient with Fanconi anemia in Polish population – case report
por: Repczynska, Anna, et al.
Publicado: (2020)

MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways
por: Li, X-J, et al.
Publicado: (2013)

Sinusoidal obstruction syndrome in a paediatric patient with acute lymphoblastic leukaemia after completion of reinduction therapy according to ALL Intercontinental Berlin-Frankfurt-Münster 2009
por: Pawlik-Gwozdecka, Dorota, et al.
Publicado: (2018)

T lymphoblastic leukaemia and the central nervous system.
por: Lilleyman, J. S., et al.
Publicado: (1981)

Long survival in childhood lymphoblastic leukaemia.
por: Chessells, J. M., et al.
Publicado: (1987)

Inotuzumab ozogamicin for acute lymphoblastic leukaemia
Publicado: (2019)

Targeted Therapy in Acute Lymphoblastic Leukaemia
por: Salvaris, Ross, et al.
Publicado: (2021)

BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia
por: Da Costa, D, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cs632pcf9ftjthmokptt1t43vr